Nazal Spray Demand Australia, Australia Healthcare Industry - Ken Research

by Ashish Kumar Market Researcher

Australia encouraged nanotechnology applications in various sectors such as energy, food, water, drug delivery and new ways to regenerate damaged parts of a human body such as blood vessels, brain, nerves, bone and cartilage. Nanotechnology is a thriving field for scientific and technological creativity in areas such as nano-materials, nano- biotechnology, electronics and photonics, energy and environment and quantum technology. Nanotechnology is used in delivering medical solutions to prevent the transmission of sexually transmitted infections. A combination of nanotechnology and ultrasound is used to replace injections with non-invasively deliver of drugs.

According to the study “Australia Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices”, the various categories in Australian drug delivery devices are central venous catheters, needle free injections, infusion systems and metered dose inhaler devices. The major key companies operating within the Australia Drug Delivery Devices market are GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others. All the new entrants in the drug delivery devices market in Australia are faced with cut throat competition due to innovative technology, quality services and diligence of international vendors.

There are various forms of drug delivery systems available in Australia for the treatment of chronic obstructive pulmonary disorders (COPD). Respiratory inhalers and nebuliser are the main forms of drug administration devices. Smart inhalers were developed with new age digital technology to improve respiratory disease management. Smart inhalers are equipped with a digital sensor that tracks the data of dosage timing, monitors the use of the inhaler, and schedules the next dosage. The respiratory inhalers are used at hospitals, clinics, respiratory care center, and other places. Nebulisers are categorised into Compressed air nebuliser, Ultrasonic nebuliser, and Mesh nebuliser. Ultrasonic nebulizers comprise of better technology compared to the jet nebulizers that are currently available. The leading vendors in respiratory inhalers market are investing heavily in the development of different kinds of inhalers and nebulizers that provide easy access to the patients. It was observed that the number of Australian population suffering from asthma and COPD are increasing drastically. COPD is the third deadly disease and can be controlled while creating awareness among the population coupled with development of new drugs.

The increasing prevalence of chronic diseases in Australia such as cancer, CVDs, hormonal disorders, and other diseases has encouraged infusion systems for medical treatment. The emerging trends in infusion systems market are encouraging the adoption of power-driven and closed infusion systems for the delivery of various medication fluids. The advances in infusion systems design and insertion of the catheter have resulted in the development of closed infusion systems. These closed infusion systems help to reduce the risk of cross-contamination or accidental contamination in patients.

The Australian health department has introduced guidelines regarding the best practices of using and managing medical drug delivery systems. The healthcare reforms and safety guidelines will witness a positive growth on the central venous catheters market. These guidelines focus on the prevention and control of healthcare-associated infections in hospitals, and outpatient sector. Australian health department has recommended the use of intravascular devices such as central venous catheters devices to reduce the associated complications. These measures have driven the growth and adoption of CVCs market in the country. The rising prevalence of cancer and cardiovascular disorders along with the rising awareness about the antimicrobial technology has encouraged the adoption of antimicrobial CVCs.

Self-administration of drugs using needle-free delivery devices was developed to avoid medical costs. Majority of the Australians self-administer medicinal drugs using a self-injectable medication which has led to a huge demand for needle-free drug delivery products. This trend also encourages pharmaceutical companies to invent new self-administration drugs. The various needle free drug delivery systems are jet injectors and transdermal drug delivery systems which are available for patients with needle phobia. Needle-free drug delivery systems are used for insulin delivery, vaccination and pain management.

The drug delivery devices are central venous catheters, needle free injections, infusion systems and metered dose inhaler devices. These devices are used to administer medicinal drugs to the patients which are dose-optimized systems with a high level of safety and efficiency. Majority of the advanced medicinal drugs are supported by drug delivery technology which meets the growing needs of patients in Australia. It was observed that the drug delivery devices market in Australia will witness a steady growing in the upcoming years. There is a huge demand for the drug delivery devices to treat the increasing health disorders developed due to westernization and industrialization.

Key Topics Covered in the Report

Australia Drug Delivery Devices Market Research Report

Australia Drug Delivery Devices Industry Performance

Australia Drug Delivery Devices Market Future Outlook

Syringes Market Growth Outlook Australia

Nebulizer’s Market Research Australia

Nazal Spray Demand Australia

Infusion Pump Demand Australia

Drug Eluting Stent Market Australia

Australia Drug Delivery Pump Consumption In Hospitals

Australia Healthcare Industry

Medical Devices Market Revenue Australia